OFG Bancorp (OFG) Drops 6.3% on February 11

Equities Staff |

OFG Bancorp (OFG) was one of the Russell 2000's biggest losers for Thursday February 11 as the stock slid 6.3% to $4.76, a loss of $-0.32 per share. Starting at an opening price of $4.92 a share, the stock traded between $4.75 and $5.14 over the course of the trading day. Volume was 434,697 shares over 3,268 trades, against an average daily volume of 777,430 shares and a total float of 43.87 million.

The losses send OFG Bancorp down to a market cap of $208.81 million. In the last year, OFG Bancorp has traded between $17.61 and $4.56, and its 50-day SMA is currently $6.48 and 200-day SMA is $9.18.

OFG Bancorp through its subsidiaries provides commercial, consumer & mortgage lending, leasing, auto loans, financial planning, insurance sales, money management & investment banking, brokerage services; & corporate & individual trust services.

OFG Bancorp is based out of San Juan, and has some 1,567 employees. Its CEO is .

For a complete fundamental analysis analysis of OFG Bancorp, check out Equities.com’s Stock Valuation Analysis report for OFG. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…